Valvular Assessment of New Generation Aortic Replacement Devices

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT06688448

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06688448
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06688448. Randomized; no masking; primary purpose treatment. Start 2024-12-01 (actual); primary completion 2026-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Valvular Assessment of New Generation Aortic Replacement Devices
Acronym
VANGUARD
Condition
Aortic Regurgitation Disease
Condition
Aortic Valve Calcification
Condition
Bicuspid Aortic Valve Disease
Intervention (Device)
Dafodil prosthesis
Intervention (Device)
Aortic Valve Replacement - Inspires Resilia prosthesis
Lead sponsor
Instituto Dante Pazzanese de Cardiologia (class: other)

Record details

Record id
cardio:ct-nct06688448
Content hash
339cfa8fae439f94ae3091a84bf037dfdcc5328c9023a4e7df3a40f4c55ca0a0